EUVIMEDEUVIMED entdecken
Open Access

Biomaterial-Based Activation Enables Scalable Expansion of Stable Human Regulatory T-cells

Jodi Graf, Aida López Ruiz, Eric D Slaughter, April M Kloxin iD, Catherine A Fromen iD

ACS Biomaterials Science & Engineering · 09.11.2026 · 12 (11) · 6511-6526

DOI: 10.1021/acsbiomaterials.6c01422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 22.10.2026. Verfasst von Jodi Graf und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of Delaware, 150 Academy Street, Newark, Delaware19716, United States. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Biocompatible Materials, Hydrogels. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NIST DOC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T-cells (Tregs) hold significant promise for the treatment of autoimmune diseases and transplant rejection, yet their clinical translation is limited by inefficient and inconsistent manufacturing strategies that fail to generate stable and functional cell populations at scale. Current ex vivo expansion approaches rely on bead-based activation systems that often induce transient FOXP3 expression and variable product quality. Here, we present a bioinspired hydrogel-based activation platform that enables robust expansion and stabilization of regulatory T-cell phenotypes from primary human T-cells. Using PEG-based hydrogels functionalized with anti-CD3 and anti-CD28, we demonstrate significantly enhanced induction and persistence of FOXP3+ T-cells compared to industry-standard bead-based activation. Hydrogel activation yields >50% FOXP3+ cells and supports sustained expression following removal of activation cues, in contrast to the transient regulatory phenotype observed with conventional methods. Importantly, hydrogel-activated cultures exhibit substantial expansion of both CD4+ and CD8+ FOXP3+ populations, alongside increased expression of key immunosuppressive cytokines including IL-10 and TGF-β. While coculture with M2-polarized macrophages modestly enriches regulatory phenotypes, it reduces overall cell expansion and provides limited benefit beyond hydrogel activation alone. These findings identify material-mediated activation as a dominant driver of Treg differentiation and stability. Together, this work establishes a scalable, biomaterial-based strategy for generating high-quality regulatory T-cell products and provides a foundation for improving the manufacturing of Treg-based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryBiocompatible MaterialsHydrogelsHumansForkhead Transcription FactorsPolyethylene GlycolsLymphocyte ActivationCells, CulturedCell Proliferation

Stichwörter der Autor:innen

T-cell activationbiomaterialscell therapyhydrogelimmunoengineeringregulatory T-cells

Substanzen

Biocompatible MaterialsHydrogelsForkhead Transcription FactorsFOXP3 protein, humanPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, University of Delaware, 150 Academy Street, Newark, Delaware19716, United States.
  • Department of Materials Science and Engineering, University of Delaware, 150 Academy Street, Newark, Delaware19716, United States.
  • Department of Biomedical Engineering, University of Delaware, 150 Academy Street, Newark, Delaware19716, United States.

ORCID-Profile: April M Kloxin, Catherine A Fromen

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NIST DOC
  • National Science Foundation Graduate Research Fellowship Program
  • National Institute of Standards and Technology
  • National Heart, Lung, and Blood Institute
  • National Institute for Innovation in Manufacturing Biopharmaceuticals
  • National Institute of General Medical Sciences

Zitieren

APA

Graf, J., López Ruiz, A., Slaughter, E. D., Kloxin, A. M., & Fromen, C. A. (2026). Biomaterial-Based Activation Enables Scalable Expansion of Stable Human Regulatory T-cells. ACS Biomaterials Science & Engineering, 12(11), 6511-6526. https://doi.org/10.1021/acsbiomaterials.6c01422

Vancouver

Graf J, López Ruiz A, Slaughter ED, Kloxin AM, Fromen CA. Biomaterial-Based Activation Enables Scalable Expansion of Stable Human Regulatory T-cells. ACS Biomaterials Science & Engineering. 2026;12(11):6511-6526. doi:10.1021/acsbiomaterials.6c01422

BibTeX
@article{Graf2026,
  author = {Graf, Jodi and López Ruiz, Aida and Slaughter, Eric D and Kloxin, April M and Fromen, Catherine A},
  title = {Biomaterial-Based Activation Enables Scalable Expansion of Stable Human Regulatory T-cells},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2026},
  volume = {12},
  number = {11},
  pages = {6511--6526},
  doi = {10.1021/acsbiomaterials.6c01422}
}
Kostenlos starten →